Potential Securities Fraud: Levi & Korsinsky Investigates Replimune Group, Inc. (REPL)
NEW YORK, NY / ACCESS Newswire / July 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Replimune Group, Inc. ("Replimune Group, Inc.") (NASDAQ:REPL) concerning possible violations of federal securities laws. On July 22, 2025, Replimune announced that it received a Complete Response Letter from the FDA rejecting its […]